Overview

Hyponatremia is one of the most common electrolyte disorders encountered in hospital and ambulatory practice. Although the disorder is defined by a low serum sodium concentration, many clinicians find it useful to translate the laboratory abnormality into an approximate sodium deficit: how many milliequivalents (mEq) of sodium would be required, in principle, to move a patient from the measured serum sodium toward a chosen therapeutic target, given an estimate of the patient’s total body water (TBW).

This calculator implements that classical relationship. It is intended as an educational adjunct to structured assessment of volume status, osmolar status, and the underlying cause of hyponatremia. It does not, by itself, determine infusion choice, infusion rate, or monitoring intensity.

Why serum sodium does not tell the whole story

Serum sodium concentration reflects the ratio of total body sodium to total body water more than it reflects total body sodium alone. Patients can be hyponatremic with low, normal, or elevated total body sodium depending on whether water retention, sodium loss, or both dominate the clinical picture. That is why expert care emphasizes classifying hyponatremia by tonicity (effective osmolality), volume status (hypovolemic, euvolemic, hypervolemic), and urine chemistry where appropriate.

Despite this complexity, a sodium-deficit estimate can still be a practical mental model when the question is framed carefully: “If I assume a simplified TBW compartment and a target serum sodium, how large is the sodium gap I am trying to close?” The answer is always an approximation, but it can help clinicians reason about orders of magnitude before fluids and medications are selected.

Concept of sodium deficit in hyponatremia

In the simplified model used by this tool, extracellular and intracellular equilibration is treated as a single combined water space for sodium balance purposes. Total body water is multiplied by the difference between the target serum sodium and the measured serum sodium (both in mEq/L, equivalent to mmol/L for sodium). The product has units of milliequivalents and is interpreted as an estimated sodium deficit relative to the stated goal.

Algebraically, the relationship is:

  • Sodium deficit (mEq) ≈ TBW (liters) × (target Na − measured Na)

When measured sodium is lower than the target, the difference is positive and the calculated deficit is positive. When the target is below the measured value, the expression becomes negative; that pattern usually signals that the chosen target is not above the current level, or that the clinical scenario is not well represented by a “replace sodium to reach a higher goal” framing.

Estimating total body water

Total body water cannot be measured at the bedside in most settings. Empirical coefficients based on sex and body weight are commonly used for adult estimates:

  • Men: TBW (L) ≈ 0.6 × weight (kg)
  • Women: TBW (L) ≈ 0.5 × weight (kg)

These coefficients are teaching tools. They systematically misestimate TBW in obesity (adipose tissue contains relatively less water than lean mass), in edematous states (extracellular expansion changes distributional assumptions), in pregnancy, and at extremes of age. For that reason, the calculator allows a custom TBW entry when a clinician prefers a different estimate derived from another method or specialist input.

Whenever TBW is uncertain, treat the sodium deficit output as proportionally uncertain. Small changes in assumed TBW produce linear changes in the calculated deficit.

Choosing a target serum sodium

Target selection is clinical and guideline-dependent. In chronic hyponatremia, many protocols emphasize cautious correction and explicit limits on the pace of change rather than rapid normalization to a “normal” laboratory midpoint. In acute or symptomatic presentations, clinicians may pursue more aggressive initial correction while still respecting upper bounds on safe rates of change to reduce the risk of osmotic demyelination.

This calculator does not pick a target for you. It requires an explicit target so that users must consciously align the tool with their clinical plan. Typical teaching examples may use targets in the mid-130s mEq/L, but the appropriate target for a specific patient may differ based on chronicity, symptoms, risk factors for osmotic demyelination, and concurrent conditions.

How to interpret the calculator output

The primary output is the estimated sodium deficit in mEq. Secondary readouts include the TBW used (estimated or custom) and the sodium concentration gap driving the calculation.

When the deficit is positive, the tool may display illustrative volumes of common intravenous fluids based on rough sodium content per liter. Those volumes are not prescriptions. Actual therapy must account for concurrent free water intake and losses, ongoing renal and extrarenal electrolyte losses, acid–base status, comorbidities, and the fact that infusates distribute across compartments over time rather than instantaneously raising serum sodium in a single-compartment model.

Safety: correction rate and osmotic demyelination

The sodium deficit estimate addresses “how much,” not “how fast.” Hyponatremia management is dominated by the rate of change in serum sodium. Overly rapid correction—particularly in chronic hyponatremia and in patients with risk factors for osmotic demyelination—can produce devastating neurological injury. Conversely, in selected acute settings, failure to correct quickly enough can allow cerebral edema to progress.

For rate planning, clinicians typically use dedicated approaches that incorporate infusate sodium concentration, TBW estimates, and sometimes urinary electrolyte-free water clearance. Many teams pair deficit thinking with explicit checks on expected change per liter of a chosen fluid and per hour of therapy. This site’s sodium correction rate tools are designed to complement, not replace, those safeguards.

When the sodium-deficit model is misleading

The estimate assumes a simplified single-pool model and stable background conditions. It becomes less reliable when there is large ongoing free water intake, aggressive diuresis, high-output drains, syndrome of inappropriate antidiuresis with rapidly changing urine osmolality, or major shifts in glucose and effective osmolality. Disorders such as translocational hyponatremia related to hyperglycemia require glucose correction logic before sodium is interpreted. Patients with severe hyperlipidemia or paraproteinemia may have pseudohyponatremia on some laboratory platforms.

In hypervolemic states (heart failure, cirrhosis, advanced kidney disease), the numerical deficit may not map cleanly onto “give sodium” because the primary problem is often water retention relative to sodium, and therapy may emphasize free water restriction, diuretic strategy, and treatment of the underlying disease rather than sodium loading.

Clinical integration checklist

Before acting on any number from this calculator, a practical sequence is to confirm that the serum sodium measurement is appropriate for the clinical context, classify volume status, review medications that affect water handling, consider adjunctive laboratory data (including serum osmolality, glucose, and relevant endocrine testing when indicated), and align any sodium-directed therapy with institutional protocols and monitoring plans.

Used with that framework, the sodium deficit estimate remains a durable teaching construct that connects laboratory values, body water assumptions, and quantitative reasoning about electrolyte therapy.